Cresset Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.3M | Buy |
47,883
+2,029
| +4% | +$695K | 0.06% | 187 |
|
|
2026
Q1 | $16.1M | Sell |
45,854
-500
| -1% | -$178K | 0.07% | 185 |
|
|
2025
Q4 | $15.2M | Buy |
46,354
+216
| +0.5% | +$68.5K | 0.06% | 189 |
|
|
2025
Q3 | $13M | Buy |
46,138
+731
| +2% | +$212K | 0.06% | 200 |
|
|
2025
Q2 | $12.7M | Sell |
45,407
-5,535
| -11% | -$1.57M | 0.06% | 186 |
|
|
2025
Q1 | $15.9M | Sell |
50,942
-954
| -2% | -$282K | 0.08% | 158 |
|
|
2024
Q4 | $13.5M | Sell |
51,896
-33,170
| -39% | -$9.84M | 0.06% | 188 |
|
|
2024
Q3 | $27.4M | Buy |
85,066
+3,192
| +4% | +$1.04M | 0.11% | 130 |
|
|
2024
Q2 | $25.6M | Buy |
81,874
+12,394
| +18% | +$3.64M | 0.11% | 126 |
|
|
2024
Q1 | $19.8M | Buy |
69,480
+2,077
| +3% | +$608K | 0.1% | 147 |
|
|
2023
Q4 | $19.4M | Sell |
67,403
-137
| -0.2% | -$37.3K | 0.12% | 124 |
|
|
2023
Q3 | $18.2M | Buy |
67,540
+4,067
| +6% | +$1.01M | 0.07% | 139 |
|
|
2023
Q2 | $14.1M | Buy |
63,473
+51,313
| +422% | +$11.9M | 0.02% | 212 |
|
|
2023
Q1 | $2.94M | Sell |
12,160
-1,879
| -13% | -$461K | 0.06% | 181 |
|
|
2022
Q4 | $3.23M | Sell |
14,039
-503
| -3% | -$135K | 0.04% | 157 |
|
|
2022
Q3 | $3.28M | Sell |
14,542
-2,274
| -14% | -$551K | 0.04% | 163 |
|
|
2022
Q2 | $4.07M | Sell |
16,816
-3,154
| -16% | -$773K | 0.05% | 142 |
|
|
2022
Q1 | $4.83M | Sell |
19,970
-3,292
| -14% | -$756K | 0.05% | 130 |
|
|
2021
Q4 | $5.23M | Sell |
23,262
-8,349
| -26% | -$1.76M | 0.05% | 137 |
|
|
2021
Q3 | $6.72M | Buy |
31,611
+3,216
| +11% | +$740K | 0.09% | 95 |
|
|
2021
Q2 | $6.92M | Sell |
28,395
-138
| -0.5% | -$33.9K | 0.1% | 83 |
|
|
2021
Q1 | $7.1M | Buy |
28,533
+1,124
| +4% | +$268K | 0.11% | 75 |
|
|
2020
Q4 | $6.3M | Sell |
27,409
-8,445
| -24% | -$1.95M | 0.1% | 75 |
|
|
2020
Q3 | $9.11M | Sell |
35,854
-1,333
| -4% | -$330K | 0.17% | 59 |
|
|
2020
Q2 | $8.77M | Sell |
37,187
-439
| -1% | -$100K | 0.19% | 50 |
|
|
2020
Q1 | $7.63M | Sell |
37,626
-3,993
| -10% | -$872K | 0.23% | 38 |
|
|
2019
Q4 | $10M | Sell |
41,619
-5,921
| -12% | -$1.31M | 0.27% | 33 |
|
|
2019
Q3 | $9.2M | Buy |
47,540
+34,270
| +258% | +$6.58M | 0.28% | 40 |
|
|
2019
Q2 | $2.44M | Sell |
13,270
-44,810
| -77% | -$8.02M | 0.08% | 108 |
|
|
2019
Q1 | $2.41M | Buy |
58,080
+54,174
| +1,387% | +$10.3M | 0.09% | 55 |
|
|
2018
Q4 | $760K | Buy |
+3,906
| New | +$762K | 0.05% | 91 |
|
Other funds holding AMGN
Cresset Asset Management's AMGN Position: Q2 2026 in Review
Cresset Asset Management increased its Amgen (AMGN) stake by 4.4% in Q2 2026, buying an estimated $695K and bringing the position to 47,883 shares worth $17.3M. The position accounts for 0.06% of the portfolio, ranked #187.
Cresset Asset Management first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $27.4M in Q3 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cresset Asset Management held 47,883 shares of Amgen worth $17.3M as of Q2 2026.
- Cresset Asset Management bought 2,029 Amgen shares in Q2 2026, an estimated $695K.
- Amgen made up 0.06% of Cresset Asset Management's portfolio in Q2 2026, its #187 holding.
- Cresset Asset Management first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- Cresset Asset Management's Amgen position peaked at $27.4M in Q3 2024.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.